Table 1

Clinical and neuroradiological features of patients with or without cognitive impairment

Cognitive impairment (+) (n=46)Cognitive impairment (−) (n=208)p Value
*Left ventricular hypertrophy, ischaemic change, or atrial fibrillation.
Statistics were by unpaired t test or χ2 test; values are mean (SD);WML, white matter lesion.
Age (y)78.0 (6.3)72.9 (6.6)<0.0001
Sex (M/F)11/3558/1500.5837
Educational level (y)7.4 (1.3)8.7 (1.9)<0.0001
History of hypertension (+)24 (52)%68 (33)%0.0140
History of diabetes mellitus (+)3 (7)%10 (5)%0.6331
Systolic blood pressure (mm Hg)159.0 (26.3)144.6 (23.0)0.0002
Diastolic blood pressure (mm Hg)76.9 (9.9)75.7 (10.3)0.4953
Blood chemistry:
    Packed cell volume0.36 (0.04)0.39 (0.04)0.0012
    Albumin (g/l)42.4 (3.4)43.0 (2.7)0.1923
    Fasting blood glucose (mmol/l)5.32 (1.20)5.22 (1.28)0.6353
    Total cholesterol (mmol/l)4.89 (1.17)5.07 (0.83)0.2130
    HDL cholesterol (mmol/l)1.45 (0.30)1.51 (0.37)0.2800
Abnormal neurological signs (+)4 (9)%12 (6)%0.4597
Abnormal ECG (+)*11 (24)%32 (15)%0.1628
MRI findings:
    %WML (%)8.25 (4.40)5.03 (4.25)<0.0001
    %Brain (%)79.0 (5.8)83.1 (6.3)<0.0001
    Cerebral infarction (+)16 (35)%38 (18)%0.0130
    (No per case)1.65 (1.04)1.65 (1.01)0.0302